These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 3432342)
1. [Improvement of the solubility of problem drugs. 15. X-ray diffraction of iomeglamic acid-methylcellulose (MH 300)-PEG 6000-coprecipitate]. Fahr F; Kala H; Pollandt P; Hückel T; Fries G Pharmazie; 1987 Aug; 42(8):554. PubMed ID: 3432342 [No Abstract] [Full Text] [Related]
2. [Improvement of the solubility of problem drugs. 15. Alteration of iomeglamic acid-methylcellulose (MH 300)-PEG 6000 coprecipitates]. Fahr F; Kala H; Pollandt P; Fries G; Hückel T Pharmazie; 1987 Aug; 42(8):552-3. PubMed ID: 3432340 [No Abstract] [Full Text] [Related]
3. [Improvement of the dissolution behavior of problem drugs. 3. X-ray diffraction measurement of iomeglamic acid/succinic acid solid dispersions]. Fahr F; Kala H; Pollandt P Pharmazie; 1985 Feb; 40(2):127-8. PubMed ID: 4001148 [No Abstract] [Full Text] [Related]
4. [Improvement of the solubility of problem drugs. 17. Processing of iomeglamic acid/methylcellulose coprecipitates in tablets]. Fahr F; Kala H; Hückel T; Fries G Pharmazie; 1988 Mar; 43(3):216. PubMed ID: 3380870 [No Abstract] [Full Text] [Related]
5. [Improvement of the solubility of problem drugs. 1. Production of iomeglamic acid fused and solidified products]. Fahr F; Kala H; Pollandt P; Wenzel U; Masthoff F Pharmazie; 1985 Jun; 40(6):408-9. PubMed ID: 4034650 [TBL] [Abstract][Full Text] [Related]
6. [Improvement of the solubility behavior of problem drugs. 20. The effect of pharmaceutical excipients on the wetability of iomeglamic acid]. Fahr F; Zessin G; Kala H; Fries G Pharmazie; 1989 Aug; 44(8):576-7. PubMed ID: 2594830 [No Abstract] [Full Text] [Related]
7. [The improvement of solubility behavior of problem drugs. 2. Solubility behavior of slow dissolving products of iomeglamic acid and succinic acid]. Fahr F; Kala H; Scharrenweber F Pharmazie; 1985 Jan; 40(1):60-1. PubMed ID: 3991791 [No Abstract] [Full Text] [Related]
8. [Improvement of the solubility of problem drugs. 18. Iomeglamic acid-PVA effervescent powder]. Fahr F; Kala H; Fries G; Helbig G Pharmazie; 1988 Mar; 43(3):217. PubMed ID: 3380871 [No Abstract] [Full Text] [Related]
9. [Improvement of the solubility behavior of problem drugs. 9. In vitro absorption studies using melting solidification products of iomeglamic acid]. Fahr F; Neubert R; Fürst W; Kala H; Masthoff F Pharmazie; 1986 Dec; 41(12):855-6. PubMed ID: 3575388 [TBL] [Abstract][Full Text] [Related]
10. [Improvement of the dissolution behavior of problem drugs. 11. DTA iomeglamic-PVP 25 copreciptates]. Fahr F; Kala H; Masthoff F; Fries G Pharmazie; 1986 Jul; 41(7):517. PubMed ID: 3774866 [No Abstract] [Full Text] [Related]
11. [The improvement of solubility behavior of problem drugs. 7. Iomeglamic acid-mannitol-melting viscosity products]. Fahr F; Kala H; Pollandt P; Zessin G Pharmazie; 1985 Oct; 40(10):733-4. PubMed ID: 3936061 [No Abstract] [Full Text] [Related]
12. [Improvement of the dissolution behavior of problem drugs. 4. Differential thermal analysis of iomeglamic acid-succinic acid embedding]. Fahr F; Kala H; Masthoff F Pharmazie; 1985 Apr; 40(4):270-1. PubMed ID: 4011664 [No Abstract] [Full Text] [Related]
13. [The enhancement of solubility of problem drugs. 5. Solubility of griseofulvin-methylcellulose-PEG coprecipitates]. Fahr F; Kala H; Diallo B; Metzner J Pharmazie; 1985 May; 40(5):362-3. PubMed ID: 4034644 [No Abstract] [Full Text] [Related]
14. Solubility of selected derivatives of 1,4-benzodiazepin-2-one in solid dispersions in PEG 6000. Cwiertnia B Acta Pol Pharm; 2006; 63(2):135-9. PubMed ID: 17514877 [TBL] [Abstract][Full Text] [Related]
15. [The improvement of solubility behavior of problem drugs. 14. Effect of properties of methylcellulose-coprecipitates on solubility]. Fahr F; Kala H; Hückel T; Fries G Pharmazie; 1987 Apr; 42(4):275. PubMed ID: 3615564 [No Abstract] [Full Text] [Related]
16. Relating solubility data of parabens in liquid PEG 400 to the behaviour of PEG 4000-parabens solid dispersions. Unga J; Tajarobi F; Norder O; Frenning G; Larsson A Eur J Pharm Biopharm; 2009 Oct; 73(2):260-8. PubMed ID: 19508891 [TBL] [Abstract][Full Text] [Related]
18. [Spectrum analysis and thermal behavior of P.E.G. 6000 in the presence of antipyrine or pyramidon]. Rambaud J; Kalantzis G; Joachim J; Pauvert B; Delarbre JL; Maury L Pharm Acta Helv; 1990; 65(9-10):280-5. PubMed ID: 2236184 [No Abstract] [Full Text] [Related]
19. A novel white film for pharmaceutical coating formed by interaction of calcium lactate pentahydrate with hydroxypropyl methylcellulose. Sakata Y; Shiraishi S; Otsuka M Int J Pharm; 2006 Jul; 317(2):120-6. PubMed ID: 16621357 [TBL] [Abstract][Full Text] [Related]